A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate if type 2 diabetics who have inadequate glycemic
control on metformin alone, have a similar, or not inferior, glycemic response when treated
with the combination of muraglitazar and metformin compared to pioglitazone and metformin.